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Abstract
Human genetic variation is the incarnation of diverse evolutionary history, which reflects both selectively advantageous and
selectively neutral change. In this study, we catalogue structural and functional features of proteins that restrain genetic
variation leading to single amino acid substitutions. Our variation dataset is divided into three categories: i) Mendelian
disease-related variants, ii) neutral polymorphisms and iii) cancer somatic mutations. We characterize structural
environments of the amino acid variants by the following properties: i) side-chain solvent accessibility, ii) main-chain
secondary structure, and iii) hydrogen bonds from a side chain to a main chain or other side chains. To address functional
restraints, amino acid substitutions in proteins are examined to see whether they are located at functionally important sites
involved in protein-protein interactions, protein-ligand interactions or catalytic activity of enzymes. We also measure the
likelihood of amino acid substitutions and the degree of residue conservation where variants occur. We show that various
types of variants are under different degrees of structural and functional restraints, which affect their occurrence in human
proteome.
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Introduction
The evolution of orthologous proteins occurs through the
establishment of amino acid substitutions in the population at rates
that depend on restraints arising from the need to maintain proper
three-dimensional structure and to retain functional interactions of
each amino acid within or between molecules [1–4]. For example,
amino acids in the cores of proteins are relatively conserved
compared with those in the solvent accessible regions [5,6] and
catalytic amino acids responsible for enzymatic reaction are also
well conserved throughout evolution. Hence, mutations tend to be
accepted in amino acid residues where evolutionary pressure is
relatively relaxed and where they can remain in the population
without selective disadvantage (or advantage). Recently, high-
throughput DNA sequencing technology has begun to have a
major impact on this field and is shedding light on genomic
sequence variations between human individuals [7–10]. Single
nucleotide polymorphisms (SNPs) in protein coding regions are of
special interest as they may be non-synonymous (nsSNPs),
resulting in changes in the types of amino acid in the protein
products. Indeed, recent analysis of human nsSNPs shows that the
majority are commonly found and appear to be functionally
neutral [11]. Thus, it is of interest to examine whether the
occurrence of coding variations in the human population is equally
affected by the factors that restrain the substitutions of amino acids
observed in divergent evolution of proteins.
Before the determination of the human genome sequence,
analysis of genetic mutations focused on establishing the
relationship between genotypes and their phenotypes, especially
susceptibility to certain disease types [12,13]. Detailed molecular
analyses of protein structure and function have shown that single
amino acid substitutions or mutations are often responsible for
certain disease types [14,15]. It has been claimed that ,60% of
such Mendelian disease mutations arise from amino acid
substitutions in their respective genes (see [16] for review). For
most monogenic diseases, a single DNA variant resulting in an
amino acid substitution is responsible for a certain disease type by
affecting protein stability and thus function [17]. Hence, much
effort has been expended to characterize the pattern of nsSNPs in
the context of sequences and structures of proteins in attempts
establish whether they are likely to be neutral or deleterious for the
functions of the organism [18–20].
One of the consensus agreements from molecular analyses of
coding variants is that, although most of them are selectively
neutral, their occurrence is restrained by various factors such as
solvent accessibility, type of secondary structure, and presence of
side-chain hydrogen bonding. Compared with benign and neutral
variants, disease-related variants are more likely to be located in
solvent inaccessible regions and tend to change the physicochem-
ical properties from those of the wild type amino acids [14,18]. In
addition, disease-related variants are more likely to be located at
conserved residues, which are believed to be functionally
important [21,22]. However, previous analyses have been based
on relatively small sub-sets of sequence variants, and have not fully
taken advantage of the rapid growing information on protein
structure and function. Hence, in the era of information deluge
from high-speed genome sequencing, high-resolution protein
structure determination, and enriched annotation on protein
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variants in the light of structure and function of proteins. This will
help us understand not only the nature of deleterious mutations,
but also the evolutionary nature of the occurrence of single amino
acid variations.
In this report, we address structural and functional restraints
that shape the occurrence of single amino acid variations. We
divide our data into three categories: i) Mendelian disease-related
variants, ii) neutral polymorphisms and iii) cancer somatic
mutations. We further characterize structural environments of
amino acid variants by mapping sequence positions onto their
corresponding three-dimensional structures if available. We
observe, as reported previously [14,18], that nsSNPs occur less
frequently at the solvent inaccessible region of proteins, whereas
disease-related mutations occur much more frequently than the
average. We also find that cancer somatic mutations and disease-
related variants occur more frequently at amino acids making
hydrogen bonds from side chains than neutral polymorphisms. We
measure substitution scores and the degree of sequence conserva-
tion at the variant positions and compare their differences by
datasets.
Results and Discussion
Compilation of Amino Acid Variant Dataset
We compiled our variant dataset from the following sources: 1)
Swiss-Prot human variants [23], 2) Ensembl human variation
database [24], and 3) COSMIC (Catalogue Of Somatic Mutation
In Cancer) database [25] (see Materials and Methods for details).
The Swiss-Prot variants are further classified by Mendelian
disease-related variants (SVD) and polymorphic variants (SVP)
according to the original annotations from the source. For
Ensembl human variations (SAP), we used only verified SNPs in
order to ensure an accurate and reliable polymorphic dataset. The
COSMIC dataset (CSM) differs from the others in that it contains
somatic mutations observed in various cancer types. The sequence
positions of variants from the source data were transferred to
UniProt protein sequence level [26] and further mapped onto
their corresponding locations in terms of three-dimensional
structures if available in PDB [27]. Table 1 shows the number
of variants from the source data, variants mapped onto UniProt
protein level, and PDB level. SVD does not share variants with
SVP, but does share 232 and 104 variants with CSM and SAP
Table 1. Four types of sequence variants and their numbers.
Sources Types Abbreviations NO. of distinct variants
from the source mapped to UniProt mapped to PDB
UniProt disease SVD 16,776 16,776 4,942
polymorphism SVP 32,748 32,748 2,895
Ensembl verified SNPs SAP 29,541 28,702 2,024
COSMIC cancer mutations CSM 5,260 4,476 2,016
doi:10.1371/journal.pone.0009186.t001
Table 2. Occurrence (%) of variants by structural environments.
Structural environment Types of variants Background
Categories types SVD
7 SVP
8 CSM
9 SAP
10 SCOP
11
solvent accessibility a
1 42.25 18.45 26.45 19.48 31.21
hydrogen bonds from side chains to main-chain amides T
2 10.69 5.79 8.44 5.69 8.55
to main-chain carbonyls T 19.50 13.01 13.27 13.36 13.63
to other side chains T 25.58 19.31 21.93 17.04 19.97
secondary structure H
3 27.98 32.98 22.14 31.58 36.61
E
4 23.25 20.23 20.26 20.13 21.09
P
5 9.71 6.40 10.26 6.60 6.45
C
6 39.06 40.39 47.34 41.69 35.85
1: inaccessible.
2: True (hydrogen bonded).
3: a-helix.
4: b-strand.
5: positive Q main-chain torsion angle.
6: coil.
7: see Dataset S1.
8: see Dataset S3.
9: see Dataset S7.
10: see Dataset S5.
11: see ‘Representative SCOP domains’ of Materials and Methods.
doi:10.1371/journal.pone.0009186.t002
Restraints of Variations
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details). CSM shares less than 0.9% either with SAP (15/4476) or
SVP (31/4476). However, SVP and SAP share ,51% (16863/
32748) and ,57% (16863/29541) with each other, which is not
surprising because both represent polymorphic variants. Consid-
ering the low percentage of overlaps amongst Mendelian disease
(SVD), cancer somatic (CSM) and neutral polymorphic variants
(SAP and SVP), we did not remove overlaps in our analysis, which
we now describe.
Local Structural Environments of Sequence Variants
We wish to characterize the local structural environments of
amino acid variants where three-dimensional structures of proteins
are known. The local structural environments of amino acids were
first defined as suggested by Overington and colleagues [28,29]: 1)
main-chain conformation and secondary structure, 2) solvent
accessibility and 3) hydrogen bonding between side chains and
main chains. In this framework, there could be 64 distinct
environments for a residue from the combination of structural
features: four from secondary structures (a-helix, b-strand, coil and
residue with positive Q main-chain torsion angle), two from solvent
accessibility (accessible and inaccessible), and eight (2
3) from
hydrogen bonds to main-chain carbonyl (CO) or amide (NH) or to
another side chain. Four types of variants were mapped onto PDB
structures and characterized by their local structural environments
(see Datasets S1, S3 and S5). In Table 2, we quantified the
proportions of variants that belong to each environmental
category and compared them among four variant classes. To give
background proportions of amino acids for each environmental
feature, we counted amino acids from representative domains (see
Materials and Methods) of SCOP families [30] and their
proportions are given in Table 2. We investigated whether the
ratio of variants for each environment category could result from
the structural restraints that shape the occurrence of variants in
proteins.
By solvent accessibility. We observed that Mendelian
disease-related variants (SVD) occur twice as often as
polymorphic variants (SVP and SAP) at solvent inaccessible
positions. For cancer mutations (CSM), the proportion of variants
in solvent inaccessible regions is more than that of SVP but less
than SVD. If a sequence variant occurs randomly in proteins, the
probability of being located in a solvent inaccessible region would
be close to 31.21%, which is the proportion of solvent inaccessible
amino acids from the representative SCOP domains. As shown in
Table 2, SVD occur 35% (42.25/31.21 -1) more than expected,
whereas polymorphic variants (SVP and SAP) occur 40% (1 -
18.45/31.21) less often than expected. We presume that the
differences in the frequency of occurrence by mutation types may
arise from evolutionary pressure, which restricts the occurrence of
variants in the core regions of proteins in order to minimize the
effects on the stabilities of proteins. This observation also agrees
with the finding that for most monogenic diseases a single DNA
variant, resulting in an amino acid substitution, is responsible for
the disease by affecting protein stability [17].
By hydrogen-bond capacity. For three categories of
hydrogen-bond types, SVD occur more frequently at amino
acids making hydrogen bonds (‘T’ in Table 2) than do the other
variants. CSM also occur more frequently than polymorphic
variants, but the difference is smaller than that of SVD. This
observation, together with the ratios of occurrence in the interior/
surface regions of proteins, clearly shows that amino acid variants
are under strong restraints, resulting in the observation that they
Figure 1. Box plots of substitution scores from four types of variants in the dataset. Each box plot is derived from the four variant datasets
(see Table 1) and data are plotted against the BLOSUM62 substitution table and ESST in A and B, respectively. The median value is represented as a
bold vertical line within a box, which represents the interquartile range (IQR) where lower quartile (cut-off at the lowest 25% of the data) and upper
quartile (cut-off at the highest 25% of the data) are the left and right edges of the box. Two vertical lines extended from the left and right hand sides
of a box represent the smallest (left whisker) and largest (right whisker) non-outlier observations, respectively. Any data observation that lies more
than 1.5*IQR lower than the lower quartile or 1.5*IQR higher than the upper quartile is considered an outlier which is shown as a circle.
doi:10.1371/journal.pone.0009186.g001
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protein structures.
By element of secondary structure. As shown in Table 2,
compared with the ratios of residues from representative SCOP
domains and other polymorphic variants (SVP and SAP), SVD
and CSM occur less in residues in a-helices (H), but more often at
residues with positive Q main-chain torsion angles (P).
Interestingly, almost half of CSM (47.34%) occur in coil regions,
distinguishing them from other variant datasets (,41.69%). Our
results agree with those of Ferrer-Costa and colleagues [18] who
showed disease-related SNPs occur less in a-helices but more
frequently in b-strands than neutral nsSNPs, although differences
in the percentages may arise from the methods used for defining
secondary structure.
Amino Acids Substitution Scores
Amino acid substitution models such as PAM [31] and
BLOSUM [32] describe the degree of substitutions as log-odd
ratio values where the positive scores suggest commonly occurring
and preferred substitutions, whereas the negative scores imply very
rare substitutions which are disfavoured in nature. Those
substitution tables were widely used to assess and predict the
effects of nsSNPs [12,18]. An ESST (Environment Specific
Substitution Table, http://www-cryst.bioc.cam.ac.uk/esst) also
describes the degree of substitution of amino acids, but differs
from PAM or BLOSUM by taking into account structural
environments which restrict the possible and allowable substitu-
tions [28,29]. Hence, ESSTs provide more accurate and
discriminating measures of substitution probabilities in a particular
environment in a three-dimensional protein structure. Figures 1A
and 1B show box plots of substitution scores from four types of
variants in the dataset using BLOSUM62 and ESST, respectively.
From both models, the median substitution scores for SVD and
CSM are lower than those of SVP and SAP. We further
investigated substitution scores by the local structural environ-
ments of the variants where they occur in three-dimensional
structures of proteins.
By solvent accessibility. Figure 2 shows box plots of
substitution scores by solvent accessibility for the four types of
variant dataset. Except for SVP, the median values of substitution
scores in the core regions of proteins are always smaller than those
from the surface regions. The difference in substitution scores
between core and surface region is highly significant for both SVD
and CSM (P,1.0
212) and significant for SVP (P,1.0
24), whereas
it is not significant for SAP (P,0.78). This suggests that, although
variants occur less frequently at solvent inaccessible regions, their
effect would be detrimental if they occurred at the solvent
inaccessible regions. In addition, the average proportions of
variants having negative values of substitution score are 63% and
55% for SVD and CSM respectively, whereas the average
proportions are less than 40% for SVP and SAP (see Table S1).
By hydrogen-bond capacity. Figure 3 shows box plots for
the distributions of substitution scores by existence or absence of
hydrogen bonds from a side chain to a main-chain amide
(Figure 3A), main-chain carbonyl (Figure 3B), and other side
chains (Figure 3C). Overall, most of the median substitution scores
for the residues making hydrogen bonds (NH/CO/SC) are
smaller or equal to those from non-hydrogen bonding residues
Figure 2. Box plots of substitution scores by solvent accessibility. Each of the four datasets is divided into solvent accessible (surface) and
inaccessible (core) datasets. The representation scheme of a box plot is the same as shown in Figure 1.
doi:10.1371/journal.pone.0009186.g002
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were to occur at amino acids making hydrogen bonds. Indeed, the
median values of SVD and CSM are negative for all three types of
hydrogen bonds, although the difference is significant (P,1.0
23)
only for amide (NH/nh) and carbonyl (CO/co) types of CSM
dataset.
By elements of secondary structure. In Figure 4, we plot
substitution scores by class of secondary structure at the position
where the variants occur. For SVD (Figure 4C) and CSM
(Figure 4D), the median values are less than zero, regardless of
secondary structures. Interestingly, for all variant types, those that
occur at positive Q main-chain torsion angles (P) are always
negative and they are significantly different (P,1.0
25) from the
distributions of substitution scores for helix (H), beta (E) and coil
(C). A positive Q torsion angle can be accommodated by a Gly,
which has no side chain, but for most other L-amino acids it leads
to disallowed interactions between side-chain and main-chain
atoms. However, for L-amino acids such as Asp or Asn,
interactions between the side-chain carbonyl group with the
carbonyl of the main-chain peptide bond can give rise to relative
stabilisation of a conformation with a positive Q angle [33]. Hence,
sequence variants occurring at the residues within a positive Q
torsion angle could be very deleterious and affect the native
structures. For a positive Q torsion angle, we found that 55,57%
of polymorphic variants (SVP and SAP) involve substitutions of
amino acids from Gly, Asp and Asn, compared to 65,68% of
SVD and CSM. This suggests that disease-causing mutations
affect the native structure more frequently than neutral
polymorphic variants (Table S2).
Amino Acid Property Substitution Matrix
Substitution scores could be a proxy for the effect of variants,
but do not provide any details of amino acid substitution types. To
investigate this, we classified 20 amino acids into six types on the
basis of physicochemical properties of amino acids (see Material
and Methods) and made 6 * 6 amino acid property substitution
matrices by counting the number of substitutions of amino acid by
their types. Figure 5 shows amino acid property substitution
matrices for the four types of variants in which the probability of
substitutions is represented as heat maps. Aliphatic amino acids
(Ala, Ile, Leu, Val and Met) from SVD (Figure 5C) and CSM
(Figure 5D) are relatively less conserved than those observed from
SAP (Figure 5A) and SVP (Figure 5B). In addition, amino acid
substitutions from negatives (Asp and Glu) to positives (Arg, His
and Lys) and aromatic (Phe, Trp, and Tyr) to polar non-charged
(Cys, Asn, Gln, Ser and Thr) types are more frequently observed
in SVD and CSM than those observed in SAP and SVP. In terms
of substitution patterns, SVP and SAP are most similar, followed
by SVD and CSM, whereas SVP and SVD are most different
(Table S3).
Figure 3. Box plots of substitution scores by hydrogen-bond types. A–C show box plots of substitution scores for the three hydrogen-bond
types from a side chain: hydrogen bonds to amides (NH/nh), to carbonyls (CO/co), and to other side chains (SC/sc). The existence and absence of
hydrogen bonds are shown in upper and lower case, respectively. The representation scheme of a box plot is the same as shown in Figure 1.
doi:10.1371/journal.pone.0009186.g003
Restraints of Variations
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Locations
We investigated the relationship between the variant types and
the degree of sequence conservation at the locations where
variants occur. Figure 6 shows box plots for the degree of sequence
conservation measured by the Shannon’s entropy (see Materials
and Methods) from the four types of variants. In Figure 6A, it is
very clear that Mendelian disease-related variants (SVD) occur at
positions where amino acids are relatively conserved compared
with those from polymorphic datasets (SVP and SAP) and cancer
somatic mutations (CSM) with significant differences in the
distribution (P,1.0
211). From Table 2, we observed that the
frequency of solvent inaccessible residues is much higher for SVD
than those from SVP, CSM and SAP. Hence, the lower sequence
entropy of SVD might arise from relatively larger fraction of
solvent inaccessible residues compared with the other variants, as
solvent inaccessible residues are more conserved than solvent
accessible residues. To address this issue, variants are classified
into either solvent accessible (Figure 6B) or inaccessible environ-
ments (Figure 6C) and their sequence entropies were measured
differently. We found that, regardless of their solvent accessibility,
SVD occur at relatively conserved regions compared with variants
from SVP, SAP and CSM (P,1.0
27 and P,0.0496 from
Figure 6B and 6C, respectively). Interestingly, as shown in
Figure 6B and 6C, the median entropy value of CSM is higher
than that of SVP and SAP, even though the distribution is not
significantly different from that of polymorphic variants (P-values
are ,0.8071, ,0.7032 and ,0.1240 from Figure 6A, 6B and 6C,
respectively). This observation contrasts with a current report that
cancer-related mutations are frequently found at evolutionarily
conserved amino acid residues whereas polymorphic variants
occur in relatively less conserved regions [34]. We suspect that the
conflict in this observation arises from differences in the nature of
the ‘cancer datasets’; we use the COSMIC database whereas the
report is based on curated lists of cancer mutations from selected
literatures.
Functional Restraints
It is well understood that amino acids responsible for specific
functions of proteins tend to be conserved throughout evolution
and are likely to be under strong restraints. Hence, mutations that
do not improve or change function in a way that confers any
selective advantage to the organism would likely be deleterious. To
test this, we investigated variants occur at amino acid residues
responsible for protein function. We used eight functional feature
types defined by UniProt annotations 2 ACT_SITE, BINDING,
CA_BIND, DISULFID, DNA_BIND, LIPID, METAL, and
NP_BIND (see Material and Methods for details) 2 and
protein-protein interaction information from PICCOLO database
(GR. Bickerton, unpublished). Table 3 shows frequencies of
functional residues having a sequence variant at the position.
Polymorphic variants (SVP and SAP) occur in less than 1% of
functional residues, whereas Mendelian disease-related variants
(SVD) occur from 1.47% for calcium-binding residues (CA_BIND)
up to 10.47% for residues interacting with a metal ion (METAL).
Cancer somatic mutations (CSM) occur less frequently than SVD
Figure 4. Box plots for the substitution scores by the class of secondary structure. A–D show box plots of substitution scores from four
variant dataset (see Table 1) which are further divided by the element of secondary structures; a-helix (H), b-strand (E), coil (C) and residue with
positive Q main-chain torsion angle (P). The representation scheme of a box plot is same as shown in Figure 1.
doi:10.1371/journal.pone.0009186.g004
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variants except for two categories: BINDING (binding sites for
chemical groups) and CA_BIND (calcium-binding regions).
In order to illustrate these features, we examined a number of
specific cases. As an example, Figure 7 exemplifies amino acid
variants occurring at functional residues mentioned above from
the following four UniProt entries: O14832, P00533, P24941, and
O00204 for A–D, respectively. In Figure 7A, there are 17
sequence variants annotated by UniProt, one of which
(VAR_050528) is annotated as polymorphic (SVP) and the rest
are disease-related variants (SVD) responsible for Refsum disease
(RD) [35–37]. Amongst 16 disease-related variants, two occur at
metal-binding (METAL) and two at ligand-binding (BINDING)
residues, which are directly responsible for the disease by inducing
the loss of activity for the protein [35,37,38]. Figure 7B illustrates
the locations of cancer somatic mutations occurring at the kinase
domain of EGFR (Epidermal Growth Factor Receptor). There are
10 ATP-binding sites and one active site residue of which 8 ATP-
binding sites are reported amongst somatic mutations responsible
for lung cancer. Figures 7C and 7D show variants in a protein
Figure 5. Amino acid property substitution matrices represented by heat maps. 20 amino acids are classified into six types based on their
physicochemical properties (see Materials and Methods) and the substitution probabilities among the six types are represented as heat maps. A–D
are from the four variant datasets in Table 1. (ALI: aliphatic, ARO: aromatic, NON: polar non-charged, POS: positively charged, NEG: negatively
charged, and NEU: neutral).
doi:10.1371/journal.pone.0009186.g005
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respectively. Two polymorphic variants (Y15S and V18L) occur
amongst 19 ATP-binding residues in Figure 7C and only one
polymorphic variant (V225I) out of 53 adenosine diphosphate
binding residues in Figure 7D. The full list of all individual variants
mentioned above is available as Datasets S2, S4 and S6.
Concluding Remarks
In this report, we show that the occurrence of amino acid
variants is affected by the structural and functional restraints.
Based on the frequency of their occurrence in particular
structural environments, disease-related variants occur more
often at solvent inaccessible regions, and at amino acid residues
making hydrogen bonds compared with polymorphic variants.
Overall, substitution scores of Mendelian disease and cancer
somatic mutations are lower than those of polymorphic variants,
suggesting deleterious and harmful effects when they occur.
However, we observe that there are polymorphic variants that
have very low substitution scores, especially variants changing the
physicochemical properties of amino acids. Indeed, the presence
of polymorphic variants (SVP and SAP) in our dataset does not
necessarily mean they are neutral with respect to the phenotypes.
There are likely to be variants related to a certain disease type,
which have not been identified yet. However, we did not attempt
to predict sequence variants causing deleterious effects on protein
structures and depriving functions, which eventually lead to a
specific disease, as they have been addressed extensively by others
[39–43]. Rather, we focused on the distributions and occurrences
of amino acid variants in terms of structural and functional
features of proteins.
Figure 6. Box plots for the degree of sequence conservation measured by Shannon’s entropy. Sequence entropies (see Material and
Methods) from the four variant datasets (Table 1) are shown as box plots in A. Sequence entropies are calculated separately according to solvent
accessibility of the variants defined by where they occur in three-dimensional structures: solvent accessible (B) and inaccessible (C). The
representation scheme of the box plots is the same as shown in Figure 1.
doi:10.1371/journal.pone.0009186.g006
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growth advantage to the tumour. However, our analysis, based on
substitution scores and amino acid property matrices, showed that
the severity of cancer somatic mutations lies between that of
Mendelian disease-related variants and polymorphic variants; less
deleteriousthanMendeliandiseasecausingvariantsbutmoresevere
than polymorphic variants. Recently, Talavera et al. [34] investi-
gated the pattern of cancer-related mutations and compared them
with those from polymorphic variants. They showed that the
distribution of cancerous amino acid substitutions is very similar to
that of polymorphism, suggesting they are under similar selection
pressures by neutral evolution, although polymorphic variants tend
to occurat less conservedpositions than cancer-related mutations.It
is known that not all somatic mutations confer growth advantage to
the cells. There are ‘driver’ somatic mutations which are the main
contributors to the development of the cancers, whereas most
somatic point mutations are likely to be ‘passengers’ that do not
contribute to oncogenesis [44]. However, it is not a trivial problem
discriminating between the two and our dataset almost certainly
contains both types, obscuring the effect of ‘driver’ mutations.
At the time of this study, reported SNPs comprise 0.46% (0.13%
for verified SNPs) of the total number of human DNA base pairs of
which 53% of SNPs occur at intergenic regions and 36% occur at
intronic region (Table S4). Only 1.26% of human SNPs occur in
protein coding regions in which more than half are non-synonymous
SNPs (0.64%) – those that have been considered in the study – and
the rest are synonymous SNPs (0.46%), frame shift (0.09%) and stop
gained mutations (0.02%). Throughout our analysis we did not take
the expression level into account; rather we assumed that proteins are
equally expressed no matter whether they contain sequence variants
or not. However, it is clear that proteins having deleterious mutations
are selectively controlled by the protein degradation system to protect
against misfolded or damaged proteins [45] and sometimes those
mutations are compensated in other species [46].
Materials and Methods
Variants Data Source
SVD and SVP are defined by annotations of UniProt human
sequence variations (http://www.uniprot.org/docs/humsavar.txt,
release: 57.5) where types of amino acids variants are classified
either disease, polymorphism or unclassified [23]. For SVD,
variants are further filtered out by removing non-Mendelian
diseases which have not been assigned any MIM number from the
OMIM (http://www.ncbi.nlm.nih.gov/omim/) database and any
disease names related with cancers from the following key tokens:
cancer, tumor, neoplasia, leukaemia, lymphoma, melanoma,
carcinoma, blastoma, and cytoma. CSM is taken from the
COSMIC (Catalogue of Somatic Mutation in Cancer, http://
www.sanger.ac.uk/genetics/CGP/cosmic/, version: 42) database
[25] from which mutations result in amino acid changes were
taken and SAP is from the Ensembl human variation database
(http://www.ensembl.org, database version: 54_36p) [24] which
compiles SNPs (Single Nucleotide Polymorphisms) mainly from
dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/)
[47]. From Ensembl human variations, we have used only verified
SNPs; genotyped and validated by the international HapMap
project [48]. Amino acid variants of CSM and SAP were
transferred onto the positions of their corresponding UniProt
sequence using the sequence alignment program, BL2SEQ, of
NCBI blast package [49] if necessary.
Representative SCOP Domains
SCOP 1.71 was used to define representative domains by
applying the following conditions:
1) NMR structures and proteins having resolution worse than
2.5 A ˚ were excluded.
2) Protein domains were clustered for each SCOP family by
running CD-HIT [50] with sequence identity of 80% or
more.
3) Within a SCOP family, the average sequence length is
maintained by removing any domains having sequence
below of (1-0.3)*mean-length and above of (1+0.3)*mean-
length.
4) Within a cluster, a protein structure having the best
resolution was selected as a representative.
Non-canonical SCOP classes (H, I, J, and K,) and membrane
and cell surface proteins (F) were not included in the process
described above.
Mapping the Location of Variants onto Three-
Dimensional Structure
To locate the position of a sequence variant in the three-
dimensional structure, variants mapped onto UniProt sequences were
further transferred onto three-dimensional structures using double-
map [51] which aligns a sequence of UniProt to its corresponding
PDB structure at residue level. In short, double-map makes two
alignments from the three sequences. The firstalignment is between a
s e q u e n c ei na t o m i cc o o r d i n a t er e c o r d( S E Q A T M )a n dS E Q R E S
record of a PDB file. The second is between SEQRES and its
corresponding UniProt sequence (SP). Using SEQRESas a reference
SP can be aligned with SEQATM and the locations of UniProt
residues can be mapped onto three-dimensional structures.
Identifying Local Structural Environment of Amino Acids
We used JOY [52] to identify the local structural environments
of amino acids. JOY consists of three supporting programs 2
SSTRUC, PSA, and HBOND 2 to annotate 1) the elements of
secondary structure, 2) solvent accessibility, 3) hydrogen bonds
from side chains, respectively. SSTRUC calculates torsion angles
within a main chain to assign secondary structure. For the
Table 3. Proportion (%) of functional residues having at least
one sequence variant.
Functional
categories
1 Types of variants
SVD
2 SVP
3 CSM
4 SAP
5
DNA_BIND 4.65 0.31 2.00 0.29
DISULFID 6.52 0.10 0.20 0.13
NP_BIND 3.91 0.25 1.39 0.32
METAL 10.47 0.21 1.16 0.18
BINDING 10.43 0.52 0.29 0.63
ACT_SITE 7.24 0.30 0.72 0.36
CA_BIND 1.47 0.54 0.22 0.51
PPI 3.53 0.83 2.15 0.51
1: see Materials and Methods for definitions.
2: see Dataset S2.
3: see Dataset S4.
4: see Dataset S8.
5: see Dataset S6.
doi:10.1371/journal.pone.0009186.t003
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total side-chain accessibility. HBOND identifies all possible
hydrogen bonds based on a distance criterion; 3.5 A ˚ between
donor and acceptor except for interactions involving sulphur
atoms where 4.0 A ˚ is used.
Amino Acid Substitution Scores
For variants at the UniProt protein sequence level, we looked up
BLOSUM62 [32] to get the substitution score for a corresponding
variant. However, substitution scores for the variants mapped onto
three-dimensional structures were from an Environment Specific
Substitution Table (ESST) [28,29] which corresponds to the local
structural environment for a variant. We used ALL-B type of
ESST, which has proved to be the best in the previous
benchmarking tests [51]. The detailed procedure of making
ESSTs is explained in our recent paper and the ESST web site
(http://www-cryst.bioc.cam.ac.uk/ESST). ESST can be generat-
ed in an automatic fashion by a recently developed computer
software Ulla [53].
Statistical Analysis
Wilcoxon rank sum test were used to calculate significant
difference in the distribution of substitution scores between two
groups. We used wilcox.test of stats package of R [54] with a two-
sided test option.
Classification of Amino Acid Types
20 amino acids are classified into 6 classes by their
physicochemical properties as follows:
1) Aliphatic (ALI): Ala, Ile, Leu, Val and Met
2) Aromatic (ARO): Phe, Trp, and Tyr
Figure 7. Examples of amino acid variations from the four datasets. UniProt feature annotations are transferred onto three-dimensional
structures of proteins by aligning UniProt sequences with their corresponding PDB sequences using double-map method [51] (see Materials and
Methods): O14832 with 2a1x in A, P00533 with 2itv in B, P24941 with 1gij in C, and O00204 with 1q1q in D. The regions not shown in the alignments
are indicated with blue arrows. Amino acid variants are shown within boxes of grey background in the alignments and as bold-frame in the structure
images. Metals and ligands are illustrated as spheres. Metal-binding (METAL), ligand-binding (BINDING), nucleotide phosphate-binding (NP_BIND),
and active sites (ACT_SITE) residues are coloured in magenta, orange, red and cyan, respectively, both in the alignments and structure images. All
structure images and alignments are drawn using PyMOL [56] and Jalview [57], respectively. (AKG: 2-Oxyglutaric acid, Fe: Iron ion, ANP:
Phosphoaminophosphonic acid-adenylate ester, 2PU: 1-(5-oxo-2,3,5,9b-tetrahydro-1h-pyrrolo[2,1- a]isoindol-9-yl)-3-(5-pyrrolidin-2-yl-1h - pyrazol-3-
yl)-urea, A3P: Adenosine-39-59-diphosphate, NHE: 2-[n-cyclohexylamino] ethane sulfonic acid).
doi:10.1371/journal.pone.0009186.g007
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4) Positively charged (POS): Arg, His and Lys
5) Negatively charged (NEG): Asp and Glu
6) Neutral (NEU): Gly and Pro
Sequence Entropy
To measure the degree of sequence conservation, we calculated
sequence entropy for each alignment position within a protein
family having at least three sequences. We skipped measuring
entropy if gaps occur in more than 50% of sequences at the
alignment position. We used Shannon’s entropy equation [55]
which can be formulated as below:
Sequence entropy ~
{
P 20
i
pilog2pi
log220
where pi is the frequency of amino acid i (of 20) at the alignment
position.
Definitions of Functional Residues
Variants taken from the four types of dataset were examined to
see whether they occur at protein residues responsible for specific
functions. We defined functional residues if they are annotated by
UniProt functional features (from ‘FT’ lines) or known to
maintain protein interactions detected by PICCOLO (GR.
Bickerton, unpublished) which is an in-house database of
protein-protein interactions between every pair of chains from
protein structures in PDB. We used eight types of UniProt
functional features:
1) ACT_SITE: amino acid(s) involved in the activity of an
enzyme
2) BINDING: binding site for any chemical group (e.g. co-
enzyme, prosthetic group, etc.)
3) CA_BIND: extent of a calcium-binding region
4) DISULFID: disulfide bonds
5) DNA_BIND: extent of a DNA-binding region
6) LIPID: covalent binding of a lipid moiety
7) METAL: binding site for a metal ion
8) NP_BIND: extent of a nucleotide phosphate-binding region
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